共 50 条
- [1] Upadacitinib: Mechanism of action, clinical, and translational science [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):
- [2] Atogepant: Mechanism of action, clinical and translational science [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):
- [3] Momelotinib: Mechanism of action, clinical, and translational science [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (08):
- [4] Evinacumab: Mechanism of action, clinical, and translational science [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (06):
- [5] Maribavir: Mechanism of action, clinical, and translational science [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):
- [6] Risankizumab: Mechanism of action, clinical and translational science [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):
- [7] Molnupiravir: Mechanism of action, clinical, and translational science [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (02):
- [8] Teclistamab: Mechanism of action, clinical, and translational science [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):
- [9] Dupilumab: Mechanism of action, clinical, and translational science [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (08):
- [10] Mobocertinib: Mechanism of action, clinical, and translational science [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (03):